Literature DB >> 17418610

Malaria transmission-blocking vaccines: the bonus of effective malaria control.

Robert W Sauerwein1.   

Abstract

Reduction of transmission is important for effective malaria control. Standard microscopic detection grossly underestimates the human transmission reservoir. Malaria transmission intensity is defined by local and focal conditions. Transmission-blocking vaccines may be effective by directly targeting identified hot spots of transmission.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17418610     DOI： 10.1016/j.micinf.2007.02.011

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  20 in total

Review 1.  Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.

Authors:  Teun Bousema; Chris Drakeley
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

2.  Development of a bivalent conjugate vaccine candidate against malaria transmission and typhoid fever.

Authors:  So Jung An; Puthupparampil V Scaria; Beth Chen; Emma Barnafo; Olga Muratova; Charles Anderson; Lynn Lambert; Myung Hwa Chae; Jae Seung Yang; Patrick E Duffy
Journal:  Vaccine       Date:  2018-04-20       Impact factor: 3.641

3.  Characterization of Plasmodium vivax transmission-blocking activity in low to moderate malaria transmission settings of the Colombian Pacific coast.

Authors:  Myriam Arévalo-Herrera; Yezid Solarte; Leonardo Rocha; Diego Alvarez; John C Beier; Sócrates Herrera
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

4.  mosGCTL-7, a C-Type Lectin Protein, Mediates Japanese Encephalitis Virus Infection in Mosquitoes.

Authors:  Ke Liu; Yingjuan Qian; Yong-Sam Jung; Bin Zhou; Ruibing Cao; Ting Shen; Donghua Shao; Jianchao Wei; Zhiyong Ma; Puyan Chen; Huaimin Zhu; Yafeng Qiu
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

Review 5.  Family members stick together: multi-protein complexes of malaria parasites.

Authors:  Andrea Kuehn; Nina Simon; Gabriele Pradel
Journal:  Med Microbiol Immunol       Date:  2010-04-24       Impact factor: 3.402

6.  Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs.

Authors:  Teun Bousema; Lucy Okell; Seif Shekalaghe; Jamie T Griffin; Sabah Omar; Patrick Sawa; Colin Sutherland; Robert Sauerwein; Azra C Ghani; Chris Drakeley
Journal:  Malar J       Date:  2010-05-24       Impact factor: 2.979

7.  Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission.

Authors:  André Lin Ouédraogo; Teun Bousema; Petra Schneider; Sake J de Vlas; Edith Ilboudo-Sanogo; Nadine Cuzin-Ouattara; Issa Nébié; Will Roeffen; Jan Peter Verhave; Adrian J F Luty; Robert Sauerwein
Journal:  PLoS One       Date:  2009-12-22       Impact factor: 3.240

8.  The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania.

Authors:  Teun Bousema; Will Roeffen; Hinta Meijerink; Harry Mwerinde; Steve Mwakalinga; Geert-Jan van Gemert; Marga van de Vegte-Bolmer; Frank Mosha; Geoffrey Targett; Eleanor M Riley; Robert Sauerwein; Chris Drakeley
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

9.  Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice.

Authors:  Nikolay S Outchkourov; Will Roeffen; Anita Kaan; Josephine Jansen; Adrian Luty; Danielle Schuiffel; Geert Jan van Gemert; Marga van de Vegte-Bolmer; Robert W Sauerwein; Hendrik G Stunnenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-10       Impact factor: 11.205

Review 10.  Acquired immunity to malaria.

Authors:  Denise L Doolan; Carlota Dobaño; J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.